Covid-19, the WHO, and the apparent collapse of traditional medical research ethics.

Godfrey B Tangwa

Indian journal of medical ethics 2021 Apr-Jun

filter terms:

africa (1)

ethics (1)

ethics research (1)

guidelines (2)

humans (1)

new england (1)

placebos (2)

research (2)

research ethics (2)

sars cov (1)

vaccines (5)

Sizes of these terms reflect their relevance to your search.

On January 14, 2021, a WHO Ad Hoc expert group published an article in the highly influential The New England Journal of Medicine, titled: "Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them" justifying the use of placebo in further trials of Covid-19 vaccines, even after purported efficacious vaccines have become available. Medical research involving human beings ought to conform strictly to principles, rules and procedures established since the Nuremberg Code (1947), especially as elaborated in the Declaration of Helsinki (2013) and the WHO/CIOMS Guidelines (2016). The NEJM article forms part of an observable trend of moral backsliding that needs to be recorded. In this paper, considering traditional medical research ethics under the impact of the Covid-19 pandemic and its ramifications and effects, and with a particular focus on the highly vulnerable populations and countries of sub-Saharan Africa, I make some relevant remarks. My arguments here are anchored in my observations as a moral philosopher though limited by my lack of expertise in any of the branches of medical science.

Citation

Godfrey B Tangwa. Covid-19, the WHO, and the apparent collapse of traditional medical research ethics. Indian journal of medical ethics. 2021 Apr-Jun;VI(2):1-12